Member since: 2015
Organization: China Pharmaceutical University
Application Area: Diagnostics
"I would recommend it to colleagues and friends. It is really convenient."
Member since: 2017
Organization: MRL Cybertec Corp.
Very good results.
Application Area:Laboratory Mainly ICU patients
"It is highly comparable to the reference institution where the hospital was previously sending their samples."
A partnership developed to transform the POC testing market
Thermo Fisher Scientific is the global collaboration partner of Samsung for commercialization and co-development of innovative solutions in the POC testing market. Together, we provide excellent expertise in clinical diagnostics to fulfill customer needs and improve patient management. For healthcare professionals facing the complexity of daily requirements in emergency situations, a new point-of-care test, Samsung IB B·R·A·H·M·S PCT, offers an integrated solution for accurate sepsis diagnosis and antibiotic stewardship. The test, which received a CE mark for use in Europe, may further improve medical decision-making about risk assessment and therapy management.
The Samsung IB B·R·A·H·M·S PCT is a rapid point-of-care (POC) immunoassay for the in vitro quantitative determination of Procalcitonin (PCT) in EDTA whole blood and plasma.